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doi:10.1016/j.jmii.2012.02.002Purpose: This study was conducted in order to determine the occurrence of esp and biofilm
formation among Enterococcus faecalis causing mastitis isolated from different bovine and
environmental origins.
Materials and methods: A total of 41 E. faecalis isolates were obtained from clinical mastitis
before antibiotic therapy, subclinical mastitis, dried manure bedding samples, and postpartum
milk samples. Isolates were screened for biofilm formation using microtiter plate method using
tryptic soy broth with 0.25% glucose as media. Isolates were tested for the presence of the esp
gene, which has been reported to be essential for biofilm formation in enterococci, by means
of the polymerase chain reaction.
Results: Analysis of the relationship between the presence of esp and the biofilm formation
capacity in E. faecalis showed that the esp gene was not identified in any of the 18 biofilm-
producing E. faecalis isolates. Moreover, two of the three non-biofilm-producing E. faecalis
strains were esp positive. In addition, the biofilm assay mean values were not changed with
different origins of isolation.
Conclusions: These results suggest the following: (1) lack of strict association between the
presence of esp and biofilm formation and (2) widespread biofilm formation capacity among
different sources of E. faecalis isolates derived from bovine mastitis.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
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Bovine mastitis remains the most costly disease in dairy
production, due to decreased milk production, increasedished by Elsevier Taiwan LLC. All rights reserved.
Role of Esp and biofilm formation by E. faecalis 81health care costs, and increased culling and death rates.1
Enterococcus faecalis is a Gram-positive commensal bacte-
rium that inhabits the oral cavity and gastrointestinal flora
of humans and animals. It represents a major agent causing
environmental bovine mastitis. These environmental patho-
gens are opportunistic invaders of the mammary gland that
live and flourish in organic bedding material, which provides
the nutrients needed for bacterial survival.2
Many persistent and recurrent infections have been
attributed to the formation of biofilms, which are struc-
tured community of bacterial cells enclosed in a self-
produced polymeric matrix and adherent to an inert or
living surface.3 Biofilm bacteria are differentiated from
their free-swimming (planktonic) counterparts, exhibiting
biofilm-specific phenotypes such as enhanced tolerance to
antibiotic treatment and increased levels of genetic
exchange.4 E. faecalis are characterized by their the innate
resistance to many commonly used antimicrobial agents
and their ability to become resistant to most, and in some
cases to all, presently available antibiotics, either by
mutation or by incorporation of foreign genetic material.5,6
In addition, they have been proven capable of producing
biofilm.7 The enhanced antibiotic tolerance resulting from
growth in a biofilm state, coupled with the intrinsic anti-
biotic resistance of the organism, serve as a reservoir for
the dissemination of antibiotic resistance genes, thereby
making treatment of biofilm-related infections a thera-
peutic challenge.
The implications of biofilms in infections and drug resis-
tance by E. faecalis have triggered an increasing interest in
the characterization of the genes involved in biofilm
formation. Despite the lack of information regarding the
genetic basis of biofilm formation by E. faecalis, some
authors underlined the role of specific cell surface protein
(Esp) of E. faecalis in biofilm formation.7 Esp is a large
surface protein with high molecular weight of unknown
function whose frequency is increased among infection-
derived E. faecalis isolates8 and that exhibits overall
sequence similarity to Bap, a biofilm-associated surface
protein of Staphylococcus aureus, previously reported to be
involved in biofilm formation.7e9 Esp consists of a nonrepeat
N-terminal domain and a central region made up of two
types of tandem repeats, which are an extensive array of
highly conserved repeat blocks designated as A and C
repeats followed by a C-terminal membrane-spanning and
anchor domain.10
Unlike strains from clinical human settings, there has not
been a systematic study of biofilm formation by E. faecalis
isolated from bovine and environmental origins in relation
to esp gene. In the present work, we studied the occur-
rence of esp and biofilm formation among E. faecalis
causing mastitis isolated from different bovine and envi-
ronmental origins for better understanding of biofilm
formation and its molecular basis by this organism.
Materials and methods
Bacterial strains
A total of 41 E. faecalis isolates were included in the study.
These isolates were obtained from clinical mastitis beforeantibiotic therapy, subclinical mastitis (SCM), dried manure
bedding samples, and postpartum milk samples collected
from three different commercial dairy farms in Egypt
under complete aseptic conditions. The animals were
confirmed for SCM using the California Mastitis Test. All
organisms presumptively identified as enterococci by
colony morphology and Gram stain were identified to the
species level using API STREP (bioMerieux Durham, NC,
USA). All isolates were stored at e20C in 20% glycerole
brain heart infusion broth for further testing.
Biofilm assay
The ability of the E. faecalis isolates to form a biofilm on an
abiotic surface was quantified as previously described7 with
some modifications in optical density (OD) reading. Briefly,
E. faecalis isolates were grown individually overnight in
tryptic soy broth (TSB) with 0.25% glucose at 37C. The
culture was diluted 1:40 in TSBe0.25% glucose, and 200 ml
of this cell suspension was used to inoculate sterile 96-well
polystyrene microtiter plates (Thermo Fisher Scientific,
Hudson, NH, USA). After 24 hours of static incubation at
37C, wells were gently washed three times with 200 ml
phosphate-buffered saline, dried in an inverted position
for 1 hour, and stained with 1% crystal violet (CV) for 15
minutes at room temperature. CV was aspirated and wells
washed 3 with sterile phosphate-buffered saline. CV was
extracted from adhering bacterial cells by addition of
200 ml of 80:20 (vol/vol) ethyl alcohol/acetone. The OD
value of the extracted CV was measured at 570 nm (OD570)
using microplate ELISA reader (BioTek, Winooski, VT, USA).
These OD values were considered as an index of bacteria
adhering to surface and forming biofilms. Wells were
examined, and the amount of biofilm formation was scored
as follows: 0Z non-biofilm formation, 1þZmoderate
biofilm formation, 2þZ strong biofilm formation. Non-
biofilm formation with OD570 is <0.5, moderate biofilm
formation with OD 570 ranged from 0.5 to 2.5, and strong
biofilm formation with OD570 is >2.5. Uninoculated wells
containing TSB with glucose (200 ml) served as the negative
control. Each assay was performed in triplicate and
repeated three times. The data were then averaged, and
standard deviation was calculated.
Polymerase chain reaction
Three different primer sets were used in polymerase chain
reaction (PCR) amplifications to detect the presence of esp
gene in DNA purified from each tested E. faecalis isolate
and simultaneously assess the repeat number variation
among these isolates. All primer sets with their sequences
are summarized in Table 1. Primers esp1 and esp3 were
used to amplify a 572-bp fragment within the N-terminal
region of esp. Primers esp46 and esp47 were used for
amplifications across the A repeat region of esp. Primers
esp2 and esp5 were used for amplifications across the C
repeat region of esp (Integrated DNA Technologies, Coral-
ville, IA, USA). Bacterial DNA was purified using DNeasy
Blood & Tissue Kit (Qiagen, Valencia, CA, USA). PCRs were
performed in a final volume of 50 ml containing 0.5 ml of
both forward and reverse primers (50 pmol), 2 ml dNTPs,
Table 1 PCR primers used in this study
Primer Sequence (50e30) Amplification size (bp) Use Source
esp1 AGGGAACGCCTTGGTATGCTAACT 572 Forward primer for amplification of esp
across the N-terminal region
This study
esp3 TGTTCCCGCTAACTCGTGGATGAA 572 Reverse primer for amplification of esp
across the N-terminal region
This study
esp46 TTACCAAGATGGTTCTGTAGGCAC Multiples of 252 bp Forward primer for amplification of esp
across the A repeats region
10
esp47 CCAAGTATACTTAGCATCTTTTGG Multiples of 252 bp Reverse primer for amplification of esp
across the A repeats region
10
Esp2 CAGATGGATCATCTGATGAAGT Multiples of 246 bp Forward primer for amplification of esp
across the C repeats region
10
Esp5 GTAACGTTACTGTTACATCTGC Multiples of 246 bp Reverse primer for amplification of esp
across the C repeats region
10
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merase, and 5 mg purified DNA. Distilled water was added to
bring the final volume to 50 ml. The cycling conditions were
as follows: 94C for 5 minutes, followed by 35 cycles of 94C
for 30 seconds, 62C for 45 seconds, 72C for 45 seconds,
and a final extension step at 72C for 10 minutes. One-tenth
of the amplified reaction mixture was mixed with gel-
loading buffer and electrophoresed in a 1% agarose gel,
and the reaction products were visualized by ethidium
bromide staining. Amplified products from esp were diges-
ted with HindIII or ClaI according to the supplier’s instruc-
tions (New England Biolabs, ElDakahlia, Mansoura, Egypt).
Statistical evaluation
Differences in the OD of the biofilms among strains with
different genotypes/phenotypes were analyzed for signifi-
cance by the Wilcoxon test for related rankable scores
using Statistica 4.1 software (StatSoft, Tulsa, OK, USA).
Results and discussion
Biofilm formation by E. faecalis isolates
A total of 41 E. faecalis isolates were recovered from
clinically mastitic cows, subclinically mastitic cows,
bedding material, and postpartum milk samples with the
percentage of 31.7%%, 19.51%, 34.14%, and 14.63%,
respectively (Table 2). These isolates were selected inTable 2 Occurrence of biofilm formation and presence of the e
Origin of isolates Enterococcus faecalis,
no. of isolates (%) Bio
Clinical mastitis 13 (31.7%) 12/
Subclinical mastitis 8 (19.51%) 6/8
Bedding 14 (34.14%) 14/
Postpartum milk samples 6 (14.63%) 6/6
Total 41 38/order to study their biofilm-producing ability in polystyrene
microtiter plates after CV staining and were scored as dis-
cussed in the Materials and methods section. OD570 readings
ranged from 0.1 to 2.9. Isolates with strong and moderate
production were considered biofilm producers. In the
tested 41 E. faecalis isolates, 38 (92.68%) isolates were
identified as biofilm producers (p < 0.001). Only three
strains recovered from clinically and subclinically mastitic
cows were not biofilm producers (7.31%) (Table 2). These
data are nearly equal to those reported by Di Rosa et al,11
who reported that 93% of 163 E. faecalis isolates derived
from clinical human samples were classified as biofilm
producers. These results are higher than those found by
other groups (with slightly different methodologies), who
reported 57%7 and 80%12 of E. faecalis isolates as positive
for biofilm formation, and lower than the percentage re-
ported in one study,13 which classified samples with ODs of
>0 as positive for biofilm formation.Biofilm formation assay mean values are not
affected by origin of isolates
Biofilm formation by E. faecalis isolated from different
origins was quantified as previously described to determine
whether the origin of E. faecalis isolates was related to the
intensity of the biofilm formation ability. Out of the 38
biofilm-producing E. faecalis isolates, 12 isolates were
recovered from clinical mastitis, six isolates from SCM, 14
isolates from bedding material, and six isolates fromsp gene in E. faecalis isolates
Enterococcus faecalis, no. of strains/total (%)
film þ esp þ
13 (92.3%) 7/13 (53.84%)
(75%) 5/8 (62.5%)
14 (100%) 6/14 (42.85%)
(100%) 4/6 (66.66%)
41 (92.68%) 22/41(53.65%) (20 biofilm producer strains
and 2 biofilm non-producer strains)
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bedding environment had similar biofilm assay mean values
as those isolated from mammary glands (p < 0.001) (Fig. 1).
Biofilm formation did not appear to be a prerequisite for
colonization of the bovine mammary gland. The data re-
ported here are in agreement with previously published
results8,12,14 showing that an ability to form biofilm is
extremely common among E. faecalis isolates, independent
of their source. Enterococcus species are described as
“environmental opportunist” in the bovine mammary
gland. A characteristic of environmental opportunist path-
ogens is that the frequency of many virulence factors in
clinical isolates is similar to the frequency in isolates in the
environment.15
Presence of esp and biofilm
PCR amplifications of esp gene was carried out using three
different sets of primers to amplify three different regions
of esp gene. PCR amplification within the N-terminal region
of esp allowed positive amplification of 572 bp in esp
positive isolates. PCR amplifications across the A repeat
and C repeat regions revealed substantial variation in band
size according to the number of repeats. This difference in
size corresponded to multiples of either 252 bp (A repeats)
or 246 bp (C repeats). The number of A repeat units varied
from two to three, while the number of C repeat units
varied from three to seven. To verify that variation
occurred in the number of A repeat units, the amplified
product in each instance was restricted with HindIII (which
cuts once within each A repeat unit), and the restriction
products were analyzed on a 1% agarose gel. In all cases,
only three restriction fragments of the expected sizes (173,
252, and 261 bp) were observed. Variation in C repeat unitsFigure 1. Biofilm formation of E. faecalis strains derived
from different origins. The data are represented by the mean
ODs of the biofilm formed by different number of biofilm
producer E. faecalis strains isolated from different bovine and
environmental sources (represented in the graph by n).
CMZ clinical mastitis; ODZ optical density; SCMZ subclinical
mastitis. All data represent the means  standard deviations
for nine determinations (three independent experiments, each
performed three times).was similarly verified by gel electrophoresis of ClaI
restriction fragments. In all cases, three restriction frag-
ments of the expected sizes (196, 246, and 434 bp) were
observed (data not shown).
The overall amplification of three different regions of
esp using the three primer pairs was the same in regard to
the total number of esp positive and negative amplifica-
tions. The esp gene was present in 22 of 41 E. faecalis
isolates (53.65%). Among clinical mastitic cows, seven
isolates (53.84%) were esp positive versus five isolates
(62.5%) from subclinical mastitic cows, six isolates (42.85%)
from bedding material, and four isolates (66.66%) from
postpartum milk samples (Table 2). Among the biofilm
producer strains (38 strains), only 20 strains were esp
positive, and esp was not detected in a total of 18 biofilm-
producing strains. In addition, two of the three E. faecalis
biofilm negative strains were esp positive. These findings
may suggest a lack of strict association between the pres-
ence of esp and biofilm formation. This is in contrast with
other studies7,16 reporting a significant correlation between
the presence of esp and the capacity to form biofilms in
their microtiter assay, suggesting that esp is involved in
biofilm formation by this organism. However, in one of
these reports,7 two esp-deficient mutants of E. faecalis
were found to be fully capable of biofilm formation. In
addition and in the same study, it was shown that disruption
of the esp gene completely impaired biofilm formation
capacity in two E. faecalis strains, whereas it did not affect
the biofilm formation capacity of a third strong biofilm
producer E. faecalis strain, suggesting the existence of esp-
dependent and esp-independent mechanisms for biofilm
development in E. faecalis. On the other hand, our results
are consistent with other later independent studies from
different laboratories that confirmed the existence of an
esp-independent biofilm formation pathway in E. fae-
calis.13,17e19 Furthermore, one of these reports18 demon-
strated that in vitro biofilm formation occurs not only in the
absence of esp, but also in the absence of the entire
pathogenicity island that harbors the esp coding sequence.
In summary, our results showed that the esp gene does
not appear to be necessary nor sufficient for the production
of biofilm in E. faecalis isolated from bovine mastitis.
We also conclude that the ability to form biofilm is
extremely common among E. faecalis isolates, independent
of their origin, and that E. faecalis have the phenotypic
characteristics of environmental opportunists to the bovine
mammary gland.
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